Literature DB >> 27547915

A probable new syndrome with the storage disease phenotype caused by the VPS33A gene mutation.

Ali Dursun1, Dilek Yalnizoglu, Omer F Gerdan, Didem Yucel-Yilmaz, Mahmut S Sagiroglu, Bayram Yuksel, Safak Gucer, Serap Sivri, Riza K Ozgul.   

Abstract

We present a novel multisystem disease in two siblings with clinical features resembling a lysosomal storage disease. These included coarse face, dysostosis multiplex, respiratory difficulty, proteinuria with glomerular foamy cells, neurological involvement with developmental delays, pyramidal signs, and severe chronic anemia. Detailed enzymatic analysis for lysosomal diseases and whole-exome sequencing studies excluded known lysosomal storage diseases in the proband. Subsequently, genome-wide genotyping and exome sequencing analysis of the family indicated two large homozygous regions on chromosomes 5 and 12, and strongly suggested that a homozygous p. R498W missense mutation in the VPS33A gene might be responsible for this novel disease. Segregation analysis in family members and mutation prediction tools' results also supported the damaging effect of the missense mutation on the function of the Vps33a protein, which plays a role in the vesicular transport system. Electron microscopic studies of the cornea of the proband showed findings supportive of dysfunction in vesicular transport. The clinical phenotype and genetic studies support the suggestion that the siblings most probably have a novel disease very likely caused by a VPS33A gene defect.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27547915     DOI: 10.1097/MCD.0000000000000149

Source DB:  PubMed          Journal:  Clin Dysmorphol        ISSN: 0962-8827            Impact factor:   0.816


  13 in total

Review 1.  The road to lysosome-related organelles: Insights from Hermansky-Pudlak syndrome and other rare diseases.

Authors:  Shanna L Bowman; Jing Bi-Karchin; Linh Le; Michael S Marks
Journal:  Traffic       Date:  2019-06       Impact factor: 6.215

Review 2.  Misdiagnosis in mucopolysaccharidoses.

Authors:  Karolina Wiśniewska; Jakub Wolski; Lidia Gaffke; Zuzanna Cyske; Karolina Pierzynowska; Grzegorz Węgrzyn
Journal:  J Appl Genet       Date:  2022-05-13       Impact factor: 2.653

Review 3.  Recent trends in mucopolysaccharidosis research.

Authors:  Hiroshi Kobayashi
Journal:  J Hum Genet       Date:  2018-11-19       Impact factor: 3.172

4.  Bi-allelic VPS16 variants limit HOPS/CORVET levels and cause a mucopolysaccharidosis-like disease.

Authors:  Kalliopi Sofou; Kolja Meier; Leslie E Sanderson; Debora Kaminski; Laia Montoliu-Gaya; Emma Samuelsson; Maria Blomqvist; Lotta Agholme; Jutta Gärtner; Chris Mühlhausen; Niklas Darin; Tahsin Stefan Barakat; Lars Schlotawa; Tjakko van Ham; Jorge Asin Cayuela; Fredrik H Sterky
Journal:  EMBO Mol Med       Date:  2021-05-03       Impact factor: 14.260

5.  Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1-dependent TFEB/TFE3 regulation.

Authors:  Reini E N van der Welle; Rebekah Jobling; Christian Burns; Paolo Sanza; Jan A van der Beek; Alfonso Fasano; Lan Chen; Fried J Zwartkruis; Susan Zwakenberg; Edward F Griffin; Corlinda Ten Brink; Tineke Veenendaal; Nalan Liv; Conny M A van Ravenswaaij-Arts; Henny H Lemmink; Rolph Pfundt; Susan Blaser; Carolina Sepulveda; Andres M Lozano; Grace Yoon; Teresa Santiago-Sim; Cedric S Asensio; Guy A Caldwell; Kim A Caldwell; David Chitayat; Judith Klumperman
Journal:  EMBO Mol Med       Date:  2021-04-14       Impact factor: 12.137

Review 6.  Precision Medicine for Lysosomal Disorders.

Authors:  Filippo Pinto E Vairo; Diana Rojas Málaga; Francyne Kubaski; Carolina Fischinger Moura de Souza; Fabiano de Oliveira Poswar; Guilherme Baldo; Roberto Giugliani
Journal:  Biomolecules       Date:  2020-07-26

7.  The lysosomal disease caused by mutant VPS33A.

Authors:  Elena V Pavlova; Aleksey Shatunov; Lena Wartosch; Alena I Moskvina; Lena E Nikolaeva; Nicholas A Bright; Karen L Tylee; Heather J Church; Andrea Ballabio; J Paul Luzio; Timothy M Cox
Journal:  Hum Mol Genet       Date:  2019-08-01       Impact factor: 6.150

Review 8.  Mucopolysaccharidosis-Plus Syndrome.

Authors:  Filipp Vasilev; Aitalina Sukhomyasova; Takanobu Otomo
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

9.  Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.

Authors:  Morag R Hunter; Geoffrey G Hesketh; Tomasz H Benedyk; Anne-Claude Gingras; Stephen C Graham
Journal:  J Mol Biol       Date:  2018-05-17       Impact factor: 5.469

Review 10.  Diagnosis of Mucopolysaccharidoses.

Authors:  Francyne Kubaski; Fabiano de Oliveira Poswar; Kristiane Michelin-Tirelli; Maira Graeff Burin; Diana Rojas-Málaga; Ana Carolina Brusius-Facchin; Sandra Leistner-Segal; Roberto Giugliani
Journal:  Diagnostics (Basel)       Date:  2020-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.